A detailed history of Summit Trail Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 6,576 shares of BAX stock, worth $218,388. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,576
Holding current value
$218,388
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$32.85 - $40.26 $216,021 - $264,749
6,576 New
6,576 $249,000
Q2 2023

Jul 25, 2023

BUY
$39.98 - $47.68 $261,029 - $311,302
6,529 New
6,529 $297,000
Q1 2018

May 21, 2018

BUY
$62.56 - $72.26 $9.96 Million - $11.5 Million
159,141 Added 6961.55%
161,427 $161,000
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $140,474 - $150,990
2,286
2,286 $158,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.